343 related articles for article (PubMed ID: 24743405)
1. [The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall].
Yamamoto H; Sugimoto S; Miyoshi K; Yamamoto H; Soh J; Yamane M; Toyooka S; Oto T; Miyoshi S
Kyobu Geka; 2014 Jan; 67(1):4-8. PubMed ID: 24743405
[TBL] [Abstract][Full Text] [Related]
2. [Chest wall lipoma mimicking a well differentiated liposarcoma; report of two cases].
Yamamoto J; Shimanouchi M; Ueda Y; Hashizume T; Suito T
Kyobu Geka; 2012 Jul; 65(7):587-90. PubMed ID: 22750838
[TBL] [Abstract][Full Text] [Related]
3. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
[TBL] [Abstract][Full Text] [Related]
4. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
6. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
[TBL] [Abstract][Full Text] [Related]
7. Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma.
Park TG; Yu YD; Park BJ; Cheon GJ; Oh SY; Kim DS; Choe JG
Clin Nucl Med; 2014 Jan; 39(1):1-7. PubMed ID: 24335565
[TBL] [Abstract][Full Text] [Related]
8. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
Kobayashi N; Fujita K; Fujisawa T; Takahashi H; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Kubota K; Saito S; Nakajima A
Gan To Kagaku Ryoho; 2008 Jan; 35(1):65-70. PubMed ID: 18195530
[TBL] [Abstract][Full Text] [Related]
9. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
[TBL] [Abstract][Full Text] [Related]
11. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT.
Lim S; Lee EH; Park JM; Chang YW; Kim HH; Jeong SH
Acta Radiol; 2013 Dec; 54(10):1117-24. PubMed ID: 23864064
[TBL] [Abstract][Full Text] [Related]
12. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.
Mertens LS; Mir MC; Scott AM; Lee ST; Fioole-Bruining A; Vegt E; Vogel WV; Manecksha R; Bolton D; Davis ID; Horenblas S; van Rhijn BW; Lawrentschuk N
Urology; 2014 Feb; 83(2):393-8. PubMed ID: 24468513
[TBL] [Abstract][Full Text] [Related]
14. Placental-site trophoblastic tumor and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
Çerçi SS; Erdemoglu E; Bozkurt KK; Yalçn Y; Erdemoglu E
Hell J Nucl Med; 2015; 18(3):264-7. PubMed ID: 26574698
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT imaging of multiple myxofibrosarcoma in left upper abdomen and chest wall.
Yi C; Wang X; Shi X; Zhang X; Chen Z
Nuklearmedizin; 2012; 51(6):N53-4. PubMed ID: 23250511
[No Abstract] [Full Text] [Related]
16. Prediction of treatment outcomes in patients with chest wall sarcoma: evaluation with PET/CT.
Nishiyama Y; Tateishi U; Kawai A; Chuman H; Nakatani F; Miyake M; Terauchi T; Inoue T; Kim EE
Jpn J Clin Oncol; 2012 Oct; 42(10):912-8. PubMed ID: 22850222
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic pitfalls in the preoperative 18F-FDG PET/CT evaluation of a case of giant malignant solitary fibrous tumor of the pleura.
Lococo F; Rapicetta C; Ricchetti T; Cavazza A; Filice A; Treglia G; Tenconi S; Paci M; Sgarbi G
Rev Esp Med Nucl Imagen Mol; 2014; 33(2):109-11. PubMed ID: 24079956
[TBL] [Abstract][Full Text] [Related]
18. Correlation between 18F-FDG-uptake and in vitro chemosensitivity of cisplatin in head and neck cancer.
Suzuki H; Nishio M; Hanai N; Hirakawa H; Tamaki T; Hasegawa Y
Anticancer Res; 2015 Feb; 35(2):1009-16. PubMed ID: 25667488
[TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT and MR imaging of CD34-negative soft-tissue solitary fibrous tumor with NAB2-STAT6 fusion gene.
Nishio J; Iwasaki H; Aoki M; Nabeshima K; Naito M
Anticancer Res; 2015 Feb; 35(2):967-71. PubMed ID: 25667482
[TBL] [Abstract][Full Text] [Related]
20. Value of positron emission tomography in full-thickness chest wall resections for malignancies.
Petermann D; Allenbach G; Schmidt S; Letovanec I; Christodoulou M; Delaloye AB; Ris HB; Prior JO
Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):406-10. PubMed ID: 19515673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
